Telehealth company Hims & Hers Health Inc. said late Monday it is in “active discussions” with Denmark’s Novo Nordisk A/S to ...

The Trump administration is preparing to announce a deal this week with Eli Lilly and Novo Nordisk to lower the price of ...

The White House is nearing an agreement with pharmaceutical companies Novo Nordisk and Eli Lilly to offer some of their ...

People looking to lose weight and lower their blood sugar may someday be able to get a single injection that turns their ...

Hims & Hers continues to sell compounded semaglutide, the active ingredient in Novo’s Wegovy and Ozempic drugs, and these ...

Hims & Hers Health (HIMS) stock rises as the company renews talks with Novo Nordisk (NVO) to sell the pharma giant's obesity drug Wegovy. Read more here.

Obesity drugs have become an increasingly popular method of weight loss but most are not covered by insurance for that ...

Ozempic, Mounjaro and Wegovy are now cultural symbols of weight loss. These medications help control blood sugar and aid ...

Novo Nordisk's new CEO is set to face intense investor scrutiny this week as the Wegovy-maker shakes up its board and pursues ...

Groundbreaking GLP-1 drugs like Ozempic, Mounjaro and Wegovy are revolutionising weight loss, with studies showing ...